Shifaa M. Abdin
- Co-authors
- Hany A. OmarMohamed HaiderGorka OriveDima W. AlhamadHasan Y. AlnissTaleb H. Al‐TelSara M. ElgendyDana M. Zaher
- Topics
- CAR-T cell therapy research (3 papers)SARS-CoV-2 and COVID-19 Research (2 papers)COVID-19 Clinical Research Studies (2 papers)
- Journals
- PLoS ONECancer ResearchLife Sciences
- Partner nations
- United Arab EmiratesEgyptUnited States
In The Last Decade
Shifaa M. Abdin
14 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Molecular Biology 416
- Oncology 167
- Pharmaceutical Science 150
- Immunology 148
- Physiology 133
Countries citing papers authored by Shifaa M. Abdin
This map shows the geographic impact of Shifaa M. Abdin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifaa M. Abdin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifaa M. Abdin more than expected).
Fields of papers citing papers by Shifaa M. Abdin
This network shows the impact of papers produced by Shifaa M. Abdin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifaa M. Abdin. The network helps show where Shifaa M. Abdin may publish in the future.
Co-authorship network of co-authors of Shifaa M. Abdin
This figure shows the co-authorship network connecting the top 25 collaborators of Shifaa M. Abdin. A scholar is included among the top collaborators of Shifaa M. Abdin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifaa M. Abdin. Shifaa M. Abdin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 42 | |
| 2 | 24 | |
| 3 | 52 | |
| 4 | 17 | |
| 5 | 31 | |
| 6 | 19 | |
| 7 | Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Reviewbreakdown → | 307 |
| 8 | 93 | |
| 9 | 64 | |
| 10 | 51 | |
| 11 | 0 | |
| 12 | 2 | |
| 13 | 224 | |
| 14 | 80 | |
| 15 | 51 |
About Shifaa M. Abdin
Shifaa M. Abdin is a scholar working on Toxicology, Geriatrics and Gerontology and Immunology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Pharmaceutical Science (150 citations), Biomaterials (110 citations) and Microbiology (52 citations). Shifaa M. Abdin has collaborated with scholars based in United Arab Emirates, Egypt and United States. Frequent co-authors include Hany A. Omar, Mohamed Haider, Gorka Orive, Dima W. Alhamad, Hasan Y. Alniss, Taleb H. Al‐Tel, Sara M. Elgendy, Dana M. Zaher, Mai F. Tolba and El‐Shaimaa A. Arafa. Their work appears in journals such as PLoS ONE, Cancer Research and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.